explore -WSS

explore

author：hotspot 2025-09-30 23:06:38 - browse：859

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： UHS says company favors patients whose insurance pays more

hotspot

WSS

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

A new crop of companies is reshaping the health data economy

Publishing genetic code of viruses could cause disaster

How state and local governments are sidelining science

The haunting brain science of long Covid

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

knowledge

explore

Gilead needs Arcellx more than ever

leisure time

In Memoriam: Notable people who died in 2023

What is STAT's opinion section for?

DIEP, the 'gold standard' of breast reconstruction, is under threat

UnitedHealth sued over use of algorithm in Medicare Advantage plans

What does generative AI mean for health care? We asked experts

Ohio still needs to do more to protect the right to abortion

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Cancer diagnosis changes perspective doctor, former hospital CEO

State Dept. review finds Biden bears some blame for Afghanistan failures

White House drug czar issues call for 'recovery

explore

Publishing genetic code of viruses could cause disaster

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

What causes rare myocarditis in young men after Covid vaccines?

Search called off for baby washed away in Pennsylvania flash flood

Experimental asthma app from Apple and Anthem shows promise

Medical school prerequisites are outdated

Wikipedia

entertainment

hotspot

Wikipedia